19.02.2013 Views

4th EucheMs chemistry congress

4th EucheMs chemistry congress

4th EucheMs chemistry congress

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Poster Session 2<br />

s1343<br />

chem. Listy 106, s257–s1425 (2012)<br />

Poster session 2 - organic <strong>chemistry</strong><br />

P - 0 9 6 1<br />

tetrAhydro-SS-CArBoLine-BASed<br />

SPiroCyCLiC LACtAM AS PotentiAL tyPe ii'<br />

SS-turn SoMAtoStAtine MiMetiC<br />

A. SACChetti 1 , A. SiLvAni 2 , G. LeSMA 2 ,<br />

M. MuSoLino 2 , r. CeCChi 3<br />

1 Polytechinc of Milan, Chemistry, Milano, Italy<br />

2 University of Milan, Chemistry, Milano, Italy<br />

3 Sanofi-Aventis, Chemistry, Milano, Italy<br />

The development of privileged molecular scaffolds<br />

efficiently mimicking reverse turn motifs has attracted remarkable<br />

interest when structural constraints are exploited to increase both<br />

binding and selectivity of model peptides. One of the successful<br />

approaches to restrict peptide conformation is the disubstitution<br />

in the a position of an a-amino acid, leading to a conformational<br />

constraint and a stereochemically stable quaternary carbon center.<br />

In particular, spirocyclic scaffolds are able to provide, upon the<br />

attachment of appropriate functional groups, useful high-affinity<br />

ligands, relevant to the field of drug discovery. [1]<br />

At present, we are interested to spirocyclic tryptophan (Trp)<br />

analogues, in order to develop new reverse turn nucleating<br />

moieties able to be inserted into pharmacologically relevant<br />

peptidomimetic compounds. Among peptides sharing a<br />

tryptophan-containing β-turn motif of which the Trp residue is<br />

critical for binding, we looked at the hormone peptide<br />

somatostatin, [2] acting in various organ systems as a<br />

neuromodulator and a neurotransmitter, as well as a potent<br />

inhibitor of various secretory processes and cell proliferation. [3]<br />

Somatostatin and its analogue octreotide (Sandostatin ® drug,<br />

clinically used for the treatment of endocrine tumors and<br />

acromegaly) are thought to interact with the sst1-5 receptors<br />

mainly by inserting a β-turn substructure, carrying a lysine (Lys)<br />

and a Trp side chain into a pocket of the G protein-coupled<br />

somatostatin receptor.<br />

We report here the preparation and structural<br />

characterization of a new 1,2,3,4-tetrahydro-β-carboline<br />

(THBC)-based spirocyclic lactam as type-II' β-turn model<br />

compound and the application of its core structure to the synthesis<br />

of a somatostatin mimetic, whose biological evaluation is under<br />

way.<br />

references:<br />

1. Van Rompaey, K. et al. D. Eur. J. Org. Chem. 2006,<br />

2899–2911.<br />

2. Janecka, A. et al. J. Pept.Res. 2001, 58, 91–107.<br />

3. Reubi, G. C. Endocrine Reviews 2003, 24, 389–427.<br />

Keywords: Conformation analysis; Peptidomimetics; Drug<br />

design;<br />

4 th <strong>EucheMs</strong> <strong>chemistry</strong> <strong>congress</strong><br />

P - 0 9 6 2<br />

Sweet tASte inveStiGAtionS on ASPArtAMe<br />

And neotAMe uSinG nMr SPeCtroSCoPy And<br />

CoMPutAtionAL MethodS<br />

B. SAGLAM 1, 2 , n. tuzun 1 , S. BeKiroGLu 2 , G. oruC 2, 3<br />

1 Istanbul Technical University, Department of Chemistry, 34469,<br />

Istanbul, Turkey<br />

2 TUBITAK Marmara Research Centre, Food Institute, 41470<br />

Gebze-Kocaeli, Turkey<br />

3 Bogazici University, Department of Chemistry, 34342, Istanbul,<br />

Turkey<br />

Email: saglambi@itu.edu.tr<br />

Aspartame (N-(L-α-Aspartyl)-L-phenylalanine,1-methyl ester)<br />

is used as an artificial, non-saccharide sweetener in the<br />

pharmaceutical and food industry and it is a dipeptide of aspartic acid<br />

and phenylalanine. [1] Neotame ((3S)-3-(3,3-Dimethylbutylamino)-<br />

-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic<br />

acid) is a nonnutritive sweetener which is a derivative of<br />

aspartame. It is a high-potency sweetener which is<br />

6000–10 000 times sweeter than sucrose and 30-60 times sweeter<br />

than aspartame. [2]<br />

The aim of this research is to determine the relationship<br />

between structure and taste for aspartame and neotame by using<br />

NMR spectroscopy. Assignment of molecules are done by using<br />

1D 1H and 13C, 2D homonuclear NOESY, TOCSY, and 2D<br />

heteronuclear HSQC NMR spectra. Molecular interactions of<br />

aspartame and neotame within cyclodextrin complexes are<br />

investigated and findings are compared with the results that are<br />

acquired from computational methods. Although aspartame and<br />

neotame have similar structures, they have different taste quality.<br />

3,3-dimethylbutyl group of neotame is the most efficient<br />

substituent that makes the difference in taste. 2<br />

references:<br />

1. Sohajda T., Beni S., Varga E., Ivanyi R., Racz A., Szente L.,<br />

Noszal B., Characterization of aspartame–cyclodextrin<br />

complexation, Journal of Pharmaceutical and Biomedical<br />

Analysis, Vol. 50, 2009, 737–745.<br />

2. Nofre C., Tinti J. M., Neotame: discovery, properties,<br />

utility, Food Chemistry, Vol. 69, 2000, 245-257.<br />

Keywords: Nmr Spectroscopy; Cyclodextrin complexes;<br />

Computational methods; Aspartame; Neotame;<br />

AUGUst 26–30, 2012, PrAGUE, cZEcH rEPUbLIc

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!